BE623673A - - Google Patents
Info
- Publication number
- BE623673A BE623673A BE623673DA BE623673A BE 623673 A BE623673 A BE 623673A BE 623673D A BE623673D A BE 623673DA BE 623673 A BE623673 A BE 623673A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- fact
- parts
- protein
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims description 33
- 210000003491 Skin Anatomy 0.000 claims description 15
- 235000018102 proteins Nutrition 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 7
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- 230000003000 nontoxic Effects 0.000 claims description 5
- 231100000252 nontoxic Toxicity 0.000 claims description 5
- 150000002500 ions Chemical class 0.000 claims description 2
- 230000002588 toxic Effects 0.000 claims description 2
- 231100000331 toxic Toxicity 0.000 claims description 2
- 229960003067 Cystine Drugs 0.000 claims 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine zwitterion Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 1
- 210000004080 Milk Anatomy 0.000 claims 1
- 241001674048 Phthiraptera Species 0.000 claims 1
- 239000005018 casein Substances 0.000 claims 1
- 235000021240 caseins Nutrition 0.000 claims 1
- 125000001145 hydrido group Chemical group *[H] 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 97
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 12
- 239000003531 protein hydrolysate Substances 0.000 description 11
- 239000000470 constituent Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 239000002304 perfume Substances 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 6
- 206010012444 Dermatitis diaper Diseases 0.000 description 5
- 208000003105 Diaper Rash Diseases 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000000454 talc Substances 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- 229960002433 Cysteine Drugs 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- 230000000844 anti-bacterial Effects 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 239000004927 clay Substances 0.000 description 3
- 229910052570 clay Inorganic materials 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 229960001305 Cysteine Hydrochloride Drugs 0.000 description 2
- 229940088598 Enzyme Drugs 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 229940059904 Light Mineral Oil Drugs 0.000 description 2
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 2
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 2
- QIJRTFXNRTXDIP-JIZZDEOASA-N [(1R)-1-carboxy-2-sulfanylethyl]azanium;chloride;hydrate Chemical compound O.Cl.SC[C@H](N)C(O)=O QIJRTFXNRTXDIP-JIZZDEOASA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- -1 polyoxyethylene stearates Polymers 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-M stearate Chemical group CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QHZLMUACJMDIAE-UHFFFAOYSA-N 1-monopalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N 2-stearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
- 206010006803 Burns third degree Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N Carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N Chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 208000010247 Contact Dermatitis Diseases 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000005005 Intertrigo Diseases 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229960004873 LEVOMENTHOL Drugs 0.000 description 1
- 235000010701 Lavanda vera Nutrition 0.000 description 1
- 240000002809 Lavandula angustifolia Species 0.000 description 1
- 235000003515 Lavandula officinalis Nutrition 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 229940041616 Menthol Drugs 0.000 description 1
- 229940050176 Methyl Chloride Drugs 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 229960005190 Phenylalanine Drugs 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040872 Skin infection Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 240000004203 Syringa vulgaris Species 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 241001106462 Ulmus Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 230000000172 allergic Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001914 calming Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 230000005591 charge neutralization Effects 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005824 corn Nutrition 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 231100000080 dermatitis contact Toxicity 0.000 description 1
- 238000007580 dry-mixing Methods 0.000 description 1
- 230000002255 enzymatic Effects 0.000 description 1
- 230000002349 favourable Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003522 irritant Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000008633 juniper tar Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- KREXGRSOTUKPLX-UHFFFAOYSA-N octadecanoic acid;zinc Chemical compound [Zn].CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O KREXGRSOTUKPLX-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001235 sensitizing Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N sorbic acid group Chemical group C(\C=C\C=C\C)(=O)O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- 239000011269 tar Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Botany (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE623673A true BE623673A (es) |
Family
ID=195720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE623673D BE623673A (es) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE623673A (es) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2035789A1 (en) * | 1969-03-31 | 1970-12-24 | Pluripharm | Acrylic acid derivs with cicatrizant action |
| EP0009404A2 (en) * | 1978-09-22 | 1980-04-02 | Unilever Plc | Water-in-oil emulsions and process for preparing them |
| WO1986002555A2 (en) * | 1984-11-02 | 1986-05-09 | Novo-Med Ag | Amino acid solution-containing drug for the treatment of cancerous diseases and preparation process thereof |
| EP0545759A1 (fr) * | 1991-11-28 | 1993-06-09 | Société BFB | Utilisation d'un acide aminé soufré, éventuellement en association avec la pyridoxine, pour la préparation d'un médicament destiné au traitement de l'eczéma |
-
0
- BE BE623673D patent/BE623673A/fr unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2035789A1 (en) * | 1969-03-31 | 1970-12-24 | Pluripharm | Acrylic acid derivs with cicatrizant action |
| EP0009404A2 (en) * | 1978-09-22 | 1980-04-02 | Unilever Plc | Water-in-oil emulsions and process for preparing them |
| EP0009404A3 (en) * | 1978-09-22 | 1981-02-25 | Unilever Plc | Water-in-oil emulsions and process for preparing them |
| WO1986002555A2 (en) * | 1984-11-02 | 1986-05-09 | Novo-Med Ag | Amino acid solution-containing drug for the treatment of cancerous diseases and preparation process thereof |
| WO1986002555A3 (fr) * | 1984-11-02 | 1986-06-19 | Novo Med Ag | Medicament contenant des solutions d'acides amines pour le traitement de maladies cancereuses et son procede de preparation |
| EP0545759A1 (fr) * | 1991-11-28 | 1993-06-09 | Société BFB | Utilisation d'un acide aminé soufré, éventuellement en association avec la pyridoxine, pour la préparation d'un médicament destiné au traitement de l'eczéma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1138739A (fr) | Composition demaquillante pour le visage et les yeux | |
| CA1341321C (fr) | Gel aqueux a base d'acide hyaluronique et d'acide desoxyribonucleique utilisable en cosmetique, et procede de preparation | |
| FR2758720A1 (fr) | Compositions cosmetiques de soins capillaires avec effet de suppression de formation de pellicules | |
| HU228522B1 (en) | Surfactant compositions | |
| EP0977550B1 (fr) | Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique | |
| US6645474B1 (en) | Stable self-tanning foams containing sodium coco-sulfate | |
| BE623673A (es) | ||
| EP3878431A1 (fr) | Composition cosmetique deodorante comprenant du zinc ricinoleate | |
| EP0593657B1 (fr) | Composition deodorante corporelle en poudre | |
| FR2576212A1 (fr) | Procede et produit pour maigrir, contenant des huiles essentielles | |
| JP4589236B2 (ja) | 化粧料 | |
| JPH029811A (ja) | 浴用剤組成物 | |
| EP0995423B1 (fr) | Poudre cosmétique et son utilisation pour le démaquillage ou le nettoyage de la peau et des muqueuses | |
| FR2683720A1 (fr) | Composition a usage cosmetique comportant des grains d'une substance gelefiee. | |
| CH412202A (fr) | Procédé de fabrication de produits cosmétiques | |
| JPS6160802B2 (es) | ||
| JP2010254630A (ja) | 化粧品類 | |
| US202246A (en) | Improvement in medical compounds | |
| JPS58183701A (ja) | 乳化安定剤 | |
| JPS59110608A (ja) | 化粧料 | |
| JP2638088B2 (ja) | 入浴剤 | |
| CA2254794A1 (fr) | Procede de preparation d'une composition cosmetique solide a base de platre et composition cosmetique ainsi obtenue | |
| FR3064470A1 (fr) | Masque ou patch prepare a partir d’une composition d’alginate | |
| US315750A (en) | Maegaeet edmotdsof | |
| FR2797397A1 (fr) | Composition cosmetique liquide non aqueuse et article cosmetique la contenant |